Charles River Laboratories International, Inc. entered into a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon, a rare disease organization, to leverage Charles River’s cell and gene contract services to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production that will be used in ex vivo cell and gene therapy. Fondazione Telethon is an Italian-based, non-profit organization and a biomedical research foundation focused on advancing cures for rar...